At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MAIA MAIA Biotechnology Inc.
Post-Market Trading 10-31 19:27:34 EDT
2.78
-0.02
-0.71%
盘后2.88
+0.10+3.60%
18:39 EDT
High2.85
Low2.70
Vol26.11K
Open2.85
D1 Closing2.80
Amplitude5.36%
Mkt Cap66.63M
Tradable Cap54.30M
Total Shares23.97M
T/O72.10K
T/O Rate0.13%
Tradable Shares19.53M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Maia Biotechnology Announces $2.44 Million Private Placement
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.